Dalfampridine Tablet, Extended Release
Product Images NDC 62756-429

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 62756-429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-dalfampridine-figure1 (Spl Dalfampridine Figure1)

The text describes a chart showing the average percent increase in walking speed from baseline for patients who either took a placebo or Dalfampridine 10 mg bid. The chart also includes the percentage of patients in each group.*

FDA Label Image

Spl-dalfampridine-figure2 (Spl Dalfampridine Figure2)

This is a table showing the percentage of patients and their average percent increase in walking speed from baseline. The table has two columns with the percentages ranging from 0% to 100% and the rows showing the placebo control group labeled BPiacebo (N=118) and the treatment group labeled B Daftanpridine 10 mg bid (N=119). The data also shows the average percent increase in walking speed for the treatment group, with the numbers ranging from 210% to >50%.*

FDA Label Image

Spl-dalfampridine-formula (Spl Dalfampridine Formula)

The first text is a formula to calculate an individual's ideal weight based on age and weight in kilograms. The second text is likely a formula to calculate Creatinine Clearance (Crol) based on Serum Creatinine level in milligrams per day, multiplied by 72.*

FDA Label Image

Spl-dalfampridine-label (Spl Dalfampridine Label)

This is a medication package of Dalfampridine Extended-Release Tablets with the National Drug Code (NDC) 62756-429-86. The pharmacist is instructed to provide a medication guide to each patient. The package contains 60 tablets and is available by prescription only. However, the rest of the text seems to be illegible due to errors.*

FDA Label Image

Spl-dalfampridine-structure (Spl Dalfampridine Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.